Claims for Patent: 10,059,925
✉ Email this page to a colleague
Summary for Patent: 10,059,925
Title: | High titer recombinant influenza viruses with enhanced replication in vero cells |
Abstract: | The invention provides a composition useful to prepare high titer influenza viruses, e.g., in the absence of helper virus, which includes internal genes from an influenza virus vaccine strain or isolate, e.g., one that is safe in humans, for instance, one that does not result in significant disease, and genes from vaccine seed virus isolates which include a HA gene segment with a HA2 sequence encoding a HA2 that confers enhanced growth in cells in culture, such as Vero cells. |
Inventor(s): | Kawaoka Yoshihiro, Horimoto Taisuke, Murakami Shin |
Assignee: | Wisconsin Alumni Research Foundation (WARF) |
Application Number: | US14816807 |
Patent Claims: |
Details for Patent 10,059,925
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Glaxosmithkline Biologicals | FLUARIX, FLUARIX QUADRIVALENT | influenza vaccine | Injection | 125127 | August 31, 2005 | 10,059,925 | 2035-08-03 |
Glaxosmithkline Biologicals | FLUARIX, FLUARIX QUADRIVALENT | influenza vaccine | Injection | 125127 | December 14, 2012 | 10,059,925 | 2035-08-03 |
Id Biomedical Corporation Of Quebec | FLULAVAL, FLULAVAL QUADRIVALENT | influenza vaccine | Injection | 125163 | October 05, 2006 | 10,059,925 | 2035-08-03 |
Id Biomedical Corporation Of Quebec | FLULAVAL, FLULAVAL QUADRIVALENT | influenza vaccine | Injection | 125163 | November 10, 2009 | 10,059,925 | 2035-08-03 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |